drugset / Trial / NCT07533851

A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.

NCT07533851

Phase 1 Completed 31 enrolled Jiangsu vcare pharmaceutical technology co., LTD
RandomizedCrossoverOpen-labelTreatment

Summary

This study will adopt a randomized, open-label, two-period, 2-way crossover design to evaluate Food effect of VC005 Tablets in healthy subjects

Timeline

Start
2026-04-23
Primary completion
2026-04-30
Completion
2026-05-29

Drugs

EvaluationDrugModalityDoseRoute
Subject VC005 Unknown Oral

Indications